NCT05486819

Brief Summary

To compare the effect of adding lignocaine and sodium bicarbonate to propofol in reducing pain on propofol injection (POPI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Aug 2022

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 2, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 4, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2023

Completed
Last Updated

September 5, 2024

Status Verified

August 1, 2024

Enrollment Period

6 months

First QC Date

August 2, 2022

Last Update Submit

August 31, 2024

Conditions

Keywords

lignocaine,sodium bicarbonate,pain on propofol injection

Outcome Measures

Primary Outcomes (1)

  • measuring the pain intensity immediately after intravenous injection of propofol using the four point verbal rating

    5 months

Secondary Outcomes (1)

  • 1. Pain intensity at any top up doses of propofol. 2. Heart rate: baseline, 5 seconds, 1 minute & 5 minutes after injection. 3. Blood pressure: baseline, immediately after assessing the pain score then 5 minutes later

    5 months

Study Arms (3)

Group (L)

ACTIVE COMPARATOR

receive 3 ml (60 mg) of lignocaine 2% added to propofol during injection

Drug: Propofol Injection

Group (B)

ACTIVE COMPARATOR

receive 3 ml of sodium bicarbonate 8.5% added to propofol during injection

Drug: Propofol Injection

Group (S)

PLACEBO COMPARATOR

receive 3 ml of normal saline added to propofol during injection

Drug: Propofol Injection

Interventions

adding lignocaine or sodium bicarbonate to propofol to reduce pain during injection

Group (B)Group (L)Group (S)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 to 65 years old.
  • Patients classified as ASA I or II.

You may not qualify if:

  • Patients with the history of allergy to propofol or lignocaine.
  • Patients took any medication for analgesia or sedation in the past 24 hours.
  • Body mass index (BMI) more than 30.
  • Patients classified as ASA III \& IV.
  • Severe mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine- Cairo University

Cairo, 11956, Egypt

Location

MeSH Terms

Interventions

Propofol

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of anesthesia , surgical icu and pain management

Study Record Dates

First Submitted

August 2, 2022

First Posted

August 4, 2022

Study Start

August 1, 2022

Primary Completion

February 2, 2023

Study Completion

February 2, 2023

Last Updated

September 5, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations